Cleared Traditional

K212419 - Magnifico Open

K212419 is the FDA 510(k) clearance for Magnifico Open by Esaote, S.P.A.. It is a Class 2 Radiology device (product code LNH) cleared through the Traditional 510(k) pathway after a 184-day FDA review.

K212419 · Esaote, S.P.A. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2022
Decision
184d
Days
Class 2
Risk

K212419 is an FDA 510(k) clearance for the Magnifico Open, Magnifico MSK. Classified as System, Nuclear Magnetic Resonance Imaging (product code LNH), Class II - Special Controls.

Submitted by Esaote, S.P.A. (Genoa, IT). The FDA issued a Cleared decision on February 4, 2022 after a review of 184 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1000 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Esaote, S.P.A. devices

Submission Details

510(k) Number K212419 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 04, 2021
Decision Date February 04, 2022
Days to Decision 184 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
77d slower than avg
Panel avg: 107d · This submission: 184d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LNH System, Nuclear Magnetic Resonance Imaging
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1000
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LNH System, Nuclear Magnetic Resonance Imaging

All 812
Devices cleared under the same product code (LNH) and FDA review panel - the closest regulatory comparables to K212419.
MAGNETOM Vida with syngo MR XA50A
K213693 · Siemens Medical Solutions USA, Inc. · Feb 2022
SIGNA Artist Evo
K213603 · Ge Healthcare (Tianjin) Company Limited · Feb 2022
smart-sync
K212271 · Northh Medical GmbH · Feb 2022
SIGNA Hero
K213668 · Ge Healthcare (Ge Medical Systems, LLC) · Jan 2022
SIGNA Prime
K211980 · Ge Healthcare (Tianjin) Company Limited · Jan 2022
Vantage Fortian 1.5T, MRT-1550, V8.0 with AiCE Reconstruction Processing Unit for MR
K213305 · Canon Medical Systems Corporation · Dec 2021